THE OPHTHALMOPATHY OF GRAVES-DISEASE

被引:9
作者
CARTER, JA [1 ]
UTIGER, RD [1 ]
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA 02115
来源
ANNUAL REVIEW OF MEDICINE | 1992年 / 43卷
关键词
OPHTHALMOPATHY; GRAVES EYE DISEASE; PROPTOSIS; EXOPHTHALMOS;
D O I
10.1146/annurev.me.43.020192.002415
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Ophthalmopathy is an integral component of Graves' disease. It usually appears at the same time as hyperthyroidism, and is characterized by proptosis (exophthalmos), periorbital and conjunctival edema, eye muscle dysfunction, and on occasion corneal ulceration or optic neuropathy. Graves' ophthalmopathy, like Graves' hyperthyroidism, is an autoimmune disease, but the mechanisms that initiate and maintain it are not known. Most patients can be treated conservatively, but a few require anti-inflammatory or surgical therapy to relieve symptoms and preserve vision.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 50 条
  • [1] PREVALENCE OF OPHTHALMOPATHY IN GRAVES-DISEASE - A PROSPECTIVE-STUDY ON 85 CASES
    VANGHELUWE, O
    DUCASSE, A
    VAUDREY, C
    MAES, B
    DELISLE, MJ
    SEGAL, A
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 1992, 15 (8-9): : 469 - 473
  • [2] IDENTIFICATION OF A SUBGROUP OF GRAVES-DISEASE PATIENTS AT HIGHER RISK FOR SEVERE OPHTHALMOPATHY AFTER RADIOIODINE
    BARTH, A
    PROBST, P
    BURGI, H
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1991, 14 (03) : 209 - 212
  • [3] Presence of ophthalmopathy in all cases of Graves' disease
    Duprey, J
    MoissonMeer, A
    Sultan, M
    Ducornet, B
    Lifchitz, E
    ANNALES D ENDOCRINOLOGIE, 1996, 57 (05) : 429 - 432
  • [4] DEVELOPMENT OF GRAVES OPHTHALMOPATHY AND UVEITIS AFTER RADIOIODINE THERAPY FOR GRAVES-DISEASE IN A PATIENT WITH HTLV-I-ASSOCIATED MYELOPATHY (HAM)
    OZAWA, Y
    MIGITA, M
    WATANABE, T
    OKUDA, I
    TAKESHITA, A
    TAKAGI, A
    SHISHIBA, Y
    INTERNAL MEDICINE, 1994, 33 (09) : 564 - 568
  • [5] GRAVES-DISEASE COMPLICATING MYELOPATHY
    FRISBIE, JH
    FISCH, B
    PARAPLEGIA, 1992, 30 (08): : 593 - 597
  • [6] HLA HAPLOTYPES AND SUSCEPTIBILITY TO GRAVES-DISEASE
    DEROSA, G
    TESTA, A
    MARIANI, M
    PURPURA, M
    GIACOMINI, D
    HORMONE RESEARCH, 1992, 37 (4-5) : 176 - 179
  • [7] Lipidomic differentiation of Graves’ ophthalmopathy in plasma and urine from Graves’ disease patients
    Seul Kee Byeon
    Se Hee Park
    Jong Cheol Lee
    Sena Hwang
    Cheol Ryong Ku
    Dong Yeob Shin
    Jin Sook Yoon
    Eun Jig Lee
    Myeong Hee Moon
    Analytical and Bioanalytical Chemistry, 2018, 410 : 7121 - 7133
  • [8] Lipidomic differentiation of Graves' ophthalmopathy in plasma and urine from Graves' disease patients
    Byeon, Seul Kee
    Park, Se Hee
    Lee, Jong Cheol
    Hwang, Sena
    Ku, Cheol Ryong
    Shin, Dong Yeob
    Yoon, Jin Sook
    Lee, Eun Jig
    Moon, Myeong Hee
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2018, 410 (27) : 7121 - 7133
  • [9] Total thyroidectomy for the treatment of recurrent Graves' disease with ophthalmopathy
    Nart, Ahmet
    Uslu, Adam
    Aykas, Ahmet
    Yuezbasioglu, Fatih
    Dogan, Murat
    Demirtas, Oezguer
    Simsek, Cenk
    ASIAN JOURNAL OF SURGERY, 2008, 31 (03) : 115 - 118
  • [10] TOCILIZUMAB IN GRAVES' OPHTHALMOPATHY: CASE SERIES
    Guzman Gil, Piery
    Loyo de Lopez, Esthela
    Tineo Rodriguez, Carmen
    Rodriguez Tejada, Catherine
    Matilde Soriano, Maria
    Valerio, Virgilio
    Romero, Harry
    Camilo Uribe, Yamell
    Sanchez Cabrera, Idelfi
    Collado Pena, Paola
    Paulino de Sanchez, Glenny
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 91 - 91